Dr. Kerryn McCluskie heads the Translational Biology effort for the Biotherapeutics programs at Codexis Inc. She received her PhD from Imperial College London, and has more than 15 years experience in drug discovery, both small molecules as well as protein therapies. Dr. McCluskie has held positions at companies of all sizes in Biotech and Pharma, and has authored 19 publications in a variety of disease areas.